Eventide Healthcare & Life Sciences Fund I (ETIHX)
57.45
+0.16
(+0.28%)
USD |
Sep 16 2026
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 1.31% | 1.734B | 0.00% | 41.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -118.01M | 43.80% |
Basic Info
| Investment Strategy | |
| The Fund seeks to provide long-term capital appreciation. The Fund will invest at least 80% of its net assets, plus borrowings for investment purposes, in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Small Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | Eventide |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
64
-118.50M
Peer Group Low
768.70M
Peer Group High
1 Year
% Rank:
77
-118.01M
-1.952B
Peer Group Low
1.887B
Peer Group High
3 Months
% Rank:
84
-377.52M
Peer Group Low
1.330B
Peer Group High
3 Years
% Rank:
73
-7.717B
Peer Group Low
963.31M
Peer Group High
6 Months
% Rank:
77
-2.065B
Peer Group Low
1.150B
Peer Group High
5 Years
% Rank:
69
-8.959B
Peer Group Low
1.534B
Peer Group High
YTD
% Rank:
77
-1.141B
Peer Group Low
982.49M
Peer Group High
10 Years
% Rank:
9
-12.70B
Peer Group Low
5.702B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of September 17, 2026.
Asset Allocation
As of March 31, 2026.
| Type | % Net |
|---|---|
| Cash | 4.52% |
| Stock | 90.88% |
| Bond | 2.06% |
| Convertible | 0.00% |
| Preferred | 1.91% |
| Other | 0.63% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Guardant Health, Inc. | 4.07% | 181.23 | 3.62% |
| Mirum Pharmaceuticals, Inc. | 4.02% | 98.39 | 1.05% |
| Insmed, Inc. | 3.78% | 123.38 | 0.65% |
|
USD Cash
|
3.66% | -- | -- |
|
BeLite Bio Inc PIPE
|
3.30% | -- | -- |
| Kymera Therapeutics, Inc. | 3.28% | 119.20 | 2.47% |
| Vaxcyte, Inc. | 3.03% | 60.72 | 3.32% |
| Apogee Therapeutics, Inc. (DELISTED) | 2.96% | 135.07 | 0.00% |
| Ionis Pharmaceuticals, Inc. | 2.72% | 46.51 | 3.72% |
| argenx SE | 2.26% | 989.36 | 0.47% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 1.10% |
| Administration Fee | 544159.0 None |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | 1.00% |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP | No |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 100000.0 None |
| Minimum Subsequent Investment | 50.00 None |
TTM Distributions
| Type | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Qualified Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Normal
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Qualified
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
LT Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Ordinary Income
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Non-Qual
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ST Cap Gains
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Interest
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Tax-Exempt
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
ROC
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Other
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
|
Total
|
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
As of August 31, 2026.
Basic Info
| Investment Strategy | |
| The Fund seeks to provide long-term capital appreciation. The Fund will invest at least 80% of its net assets, plus borrowings for investment purposes, in equity and equity-related securities of companies in the healthcare and life sciences sectors, including common stock, options, preferred stock and convertible debt. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Small Cap Growth |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Global Peer Group | Equity Sector Healthcare |
| Peer Group | Health/Biotechnology Funds |
| Global Macro | Equity Industry Sector |
| US Macro | Sector Equity Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Health/Biotechnology Funds |
| Fund Owner Firm Name | Eventide |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (9-15-26) | 1.29% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | 88 |
| Stock | |
| Weighted Average PE Ratio | 36.90 |
| Weighted Average Price to Sales Ratio | 21.88 |
| Weighted Average Price to Book Ratio | 11.06 |
| Weighted Median ROE | -82.48% |
| Weighted Median ROA | -30.85% |
| Return on Investment (TTM) | -34.80% |
| Earning Yield | 0.0317 |
| LT Debt / Shareholders Equity | 0.9794 |
| Number of Equity Holdings | 81 |
As of March 31, 2026
Growth Metrics
| EPS Growth (1Y) | 1.10% |
| EPS Growth (3Y) | 28.08% |
| EPS Growth (5Y) | 10.66% |
| Sales Growth (1Y) | 42.37% |
| Sales Growth (3Y) | 39.33% |
| Sales Growth (5Y) | 26.62% |
| Sales per Share Growth (1Y) | 617.8% |
| Sales per Share Growth (3Y) | 48.91% |
| Operating Cash Flow - Growth Rate (3Y) | 34.81% |
As of March 31, 2026
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:ETIHX", "name") |
| Broad Asset Class: =YCI("M:ETIHX", "broad_asset_class") |
| Broad Category: =YCI("M:ETIHX", "broad_category_group") |
| Prospectus Objective: =YCI("M:ETIHX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |